• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白型心脏淀粉样变性患者心肌灌注的全球和区域减少:一项使用锝焦磷酸盐和铊的双SPECT研究

Global and Regional Reduction of Myocardial Perfusion in Patients with Transthyretin Type of Cardiac Amyloidosis: A Dual SPECT Study Using Tc Pyrophosphate and Thallium.

作者信息

Suenaga Hiroki, Fukushima Kenji, Ishii Shiro, Hasegawa Osamu, Muto Yuuki, Yamakuni Ryo, Sugawara Shigeyasu, Sekino Hirofumi, Sato Akihiko, Oikawa Masayoshi, Takeishi Yasuchika, Ito Hiroshi

机构信息

Department of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan.

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

出版信息

Ann Nucl Cardiol. 2024;10(1):16-22. doi: 10.17996/anc.23-00009. Epub 2024 Oct 31.

DOI:10.17996/anc.23-00009
PMID:39635327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612393/
Abstract

: We aimed to clarify the clinical characteristics of global and regional myocardial perfusion in patients with transthyretin type of cardiac amyloidosis (ATTR) using dual single-photon emission computed tomography (SPECT) with Tc pyrophosphate (PYP) and TL (TL). : Consecutive 178 (mean age 78±12, male 79) patients known or suspect of ATTR who underwent PYP-TL dual SPECT were retrospectively enrolled. Patients were categorized according to the visual grading for planar PYP uptake using Perugini grading, and the patients with grade greater than or equal to 2 were analyzed. In planar analysis, the heart/contralateral ratio (H/CL) for PYP, and heart/lung ratio (H/L) for TL were obtained to evaluate global myocardial uptake. In TL-SPECT polar map analysis, the heterogeneity of myocardial uptake was evaluated using segmental mean %uptake. Cardiac function and left ventricular function and end-diastolic ventricular mass (LVmass) were measured by echocardiography. : Among 178 patients, 39 patients showed PYP uptake with grade 2 or 3 and H/CL >1.3 (81±5 ys, male 28). Of those, 4 patients showed significant perfusion defect in TL scan. Among 35 patients without perfusion defect, H/L showed a significant inverse correlation to H/CL, and LVmass (r=-0.3, p=0.02; r=-0.4, p=0.03. 95% confidence interval -0.4 to 0.2, and -0.7 to -0.04 for H/CL and LVmass). Polar map analysis demonstrated significantly lower mean %uptake for TL in septum compared to lateral (79.4±8.4 vs. 84.3±6.2, p=0.006 for TL in septum vs. lateral, respectively). : In ATTR, TL uptake surrogated the reduction of global myocardial perfusion. A significant regional heterogeneity was observed with a notable reduction in septum despite the diffuse hypertrophy.

摘要

我们旨在通过使用焦磷酸锝(PYP)和替曲膦(TL)的双单光子发射计算机断层扫描(SPECT)来阐明转甲状腺素蛋白型心脏淀粉样变性(ATTR)患者整体和局部心肌灌注的临床特征。连续纳入178例已知或疑似ATTR且接受PYP-TL双SPECT检查的患者(平均年龄78±12岁,男性79例)。根据使用佩鲁吉尼分级对平面PYP摄取的视觉分级对患者进行分类,并对分级大于或等于2的患者进行分析。在平面分析中,获取PYP的心脏/对侧比值(H/CL)和TL的心脏/肺比值(H/L)以评估整体心肌摄取。在TL-SPECT极坐标图分析中,使用节段平均摄取百分比评估心肌摄取的异质性。通过超声心动图测量心功能、左心室功能和舒张末期心室质量(LVmass)。在178例患者中,39例患者PYP摄取分级为2或3且H/CL>1.3(81±5岁,男性28例)。其中,4例患者在TL扫描中显示明显的灌注缺损。在35例无灌注缺损的患者中,H/L与H/CL以及LVmass呈显著负相关(r=-0.3,p=0.02;r=-0.4,p=0.03。H/CL和LVmass的95%置信区间分别为-0.4至0.2和-0.7至-0.04)。极坐标图分析显示,与侧壁相比,TL在间隔的平均摄取百分比显著降低(TL在间隔与侧壁分别为79.4±8.4对84.3±6.2,p=0.006)。在ATTR中,TL摄取替代了整体心肌灌注的降低。观察到明显的区域异质性,尽管存在弥漫性肥厚,但间隔有明显减少。

相似文献

1
Global and Regional Reduction of Myocardial Perfusion in Patients with Transthyretin Type of Cardiac Amyloidosis: A Dual SPECT Study Using Tc Pyrophosphate and Thallium.转甲状腺素蛋白型心脏淀粉样变性患者心肌灌注的全球和区域减少:一项使用锝焦磷酸盐和铊的双SPECT研究
Ann Nucl Cardiol. 2024;10(1):16-22. doi: 10.17996/anc.23-00009. Epub 2024 Oct 31.
2
Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.疑似心脏淀粉样变性患者的锝-99m焦磷酸钠/铊-201双同位素同时心肌单光子发射计算机断层显像
J Nucl Cardiol. 2020 Feb;27(1):28-37. doi: 10.1007/s12350-019-01753-5. Epub 2019 Jun 6.
3
Comparison of 1-h with 3-h planar Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.用 SPECT 作为参考标准比较 1 小时与 3 小时平面 Tc-焦磷酸盐闪烁显像在疑似转甲状腺素蛋白心脏淀粉样变性患者中的应用。
Ann Nucl Med. 2023 Feb;37(2):99-107. doi: 10.1007/s12149-022-01807-8. Epub 2022 Nov 10.
4
Inter-observer reproducibility and intra-observer repeatability in Tc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis.三价焦磷酸盐扫描解读诊断转甲状腺素蛋白心脏淀粉样变性的观察者间重现性和观察者内可重复性。
J Nucl Cardiol. 2022 Apr;29(2):440-446. doi: 10.1007/s12350-020-02353-4. Epub 2020 Sep 11.
5
Lateral Planar Imaging of Tc-pyrophosphate Scintigraphy in Patients with Suspected Transthyretin Cardiac Amyloidosis.疑似转甲状腺素蛋白心脏淀粉样变性患者的Tc-焦磷酸盐闪烁扫描术的平面侧位成像
Ann Nucl Cardiol. 2024;10(1):29-37. doi: 10.17996/anc.24-00002. Epub 2024 Oct 31.
6
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术:预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
7
Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.用特立氟胺治疗转甲状腺素蛋白心脏淀粉样变患者后的 Tc-99m 焦磷酸盐心脏扫描随访。
Jpn J Radiol. 2023 Aug;41(8):882-888. doi: 10.1007/s11604-023-01403-4. Epub 2023 Mar 15.
8
Quantitative Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy.定量 Tc-焦磷酸盐心肌摄取:转甲状腺素蛋白稳定治疗的变化。
J Nucl Cardiol. 2024 Sep;39:102019. doi: 10.1016/j.nuclcard.2024.102019. Epub 2024 Aug 10.
9
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
10
Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy.锝-99m焦磷酸盐单光子发射计算机断层扫描/计算机断层扫描在监测遗传性转甲状腺素蛋白淀粉样心肌病患者RNA干扰疗法治疗变化中的应用。
J Formos Med Assoc. 2025 Apr;124(4):333-339. doi: 10.1016/j.jfma.2024.10.005. Epub 2024 Oct 10.

引用本文的文献

1
Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomography/computed tomography: a single-center, cross-sectional study.使用定量单光子发射计算机断层扫描/计算机断层扫描对经活检证实的转甲状腺素蛋白淀粉样心肌病中区域摄取异质性与心脏功能障碍进行鉴别和相关性分析:一项单中心横断面研究。
EJNMMI Res. 2025 Aug 1;15(1):97. doi: 10.1186/s13550-025-01292-w.
2
Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-Depth Review of Techniques and Clinical Applications.非缺血性心肌病的心血管磁共振心肌灌注成像:技术与临床应用的深入综述
Medicina (Kaunas). 2025 May 10;61(5):875. doi: 10.3390/medicina61050875.

本文引用的文献

1
Cardiac Amyloidosis: Current Diagnostic Strategies Using Multimodality Imaging.心脏淀粉样变性:使用多模态成像的当前诊断策略
Ann Nucl Cardiol. 2020;6(1):67-73. doi: 10.17996/anc.20-00130. Epub 2020 Aug 31.
2
Global and Regional Variations in Transthyretin Cardiac Amyloidosis: A Comparison of Longitudinal Strain and Tc-Pyrophosphate Imaging.全球和区域间转甲状腺素蛋白心脏淀粉样变的差异:纵向应变与 Tc-焦磷酸盐成像比较。
J Nucl Med Technol. 2022 Mar;50(1):30-37. doi: 10.2967/jnmt.120.261893. Epub 2021 Dec 21.
3
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination.
未经挑选的老年患者尸检中隐匿性心脏淀粉样变的发病率及特征
Front Cardiovasc Med. 2021 Nov 23;8:749523. doi: 10.3389/fcvm.2021.749523. eCollection 2021.
4
Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis: Results From TOPCAT.螺内酯在超声心动图表现为射血分数保留型心衰(HFpEF)且疑似心脏淀粉样变性患者中的应用:来自 TOPCAT 的结果。
JACC Heart Fail. 2021 Nov;9(11):795-802. doi: 10.1016/j.jchf.2021.06.007. Epub 2021 Sep 8.
5
Complementary role of hybrid imaging with SPECT myocardial perfusion and coronary CT angiography in hypertrophic cardiomyopathy.SPECT心肌灌注与冠状动脉CT血管造影混合成像在肥厚型心肌病中的互补作用。
J Nucl Cardiol. 2022 Oct;29(5):2716-2720. doi: 10.1007/s12350-020-02497-3. Epub 2021 Jan 6.
6
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性:不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
7
Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".心尖部变异型肥厚型心肌病的“多模态影像学评估”
Int J Cardiovasc Imaging. 2020 Mar;36(3):553-561. doi: 10.1007/s10554-019-01739-x. Epub 2019 Dec 18.
8
How to Image Cardiac Amyloidosis: A Practical Approach.如何成像心脏淀粉样变性:实用方法。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1368-1383. doi: 10.1016/j.jcmg.2019.07.015. Epub 2019 Oct 11.
9
Myocardial Amyloidosis: The Exemplar Interstitial Disease.心肌淀粉样变性:典型的间质性疾病。
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2345-2356. doi: 10.1016/j.jcmg.2019.06.023. Epub 2019 Aug 14.
10
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术:预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.